Aptorum Group shareholders approve merger with DiamiR Biosciences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil rises as renewed US-Iran strikes stoke supply fears
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences
June 10, 2026 8:00 AM EDTNEW YORK, NY, June 10, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company dedicated to addressing unmet medical needs, today announced that at its shareholder meeting held on June 9, 2026, its shareholders voted to approve the proposed merger transaction with DiamiR Biosciences Corp. (DiamiR), a developer of innovative blood-based diagnostic tests for brain health and other diseases.
The approval by Aptorum Groups shareholders represents a significant milestone toward completing the previously announced all-stock merger transaction, pursuant to which DiamiR will... More
